TD Private Client Wealth LLC raised its stake in shares of Relx Plc (NYSE:RELX – Free Report) by 7.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 4,943 shares of the technology company’s stock after purchasing an additional 354 shares during the quarter. TD Private Client Wealth LLC’s holdings in Relx were worth $224,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. FMR LLC lifted its stake in shares of Relx by 8.3% in the 3rd quarter. FMR LLC now owns 7,148,837 shares of the technology company’s stock valued at $339,284,000 after purchasing an additional 548,423 shares in the last quarter. Natixis Advisors LLC raised its holdings in Relx by 2.8% in the fourth quarter. Natixis Advisors LLC now owns 1,202,592 shares of the technology company’s stock valued at $54,622,000 after buying an additional 32,739 shares during the period. Captrust Financial Advisors lifted its position in Relx by 3.4% during the third quarter. Captrust Financial Advisors now owns 1,103,797 shares of the technology company’s stock valued at $52,386,000 after buying an additional 35,807 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in Relx during the fourth quarter worth approximately $44,516,000. Finally, JPMorgan Chase & Co. increased its position in shares of Relx by 14.6% in the third quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company’s stock worth $39,225,000 after acquiring an additional 104,999 shares in the last quarter. Hedge funds and other institutional investors own 15.02% of the company’s stock.
Relx Price Performance
RELX opened at $50.39 on Wednesday. Relx Plc has a twelve month low of $40.25 and a twelve month high of $51.99. The firm has a market cap of $93.53 billion, a price-to-earnings ratio of 27.09, a PEG ratio of 2.73 and a beta of 0.90. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The company has a fifty day simple moving average of $49.34 and a 200 day simple moving average of $47.76.
Relx Increases Dividend
Analysts Set New Price Targets
RELX has been the subject of a number of research reports. Barclays raised shares of Relx from an “equal weight” rating to an “overweight” rating in a research report on Friday, March 14th. StockNews.com downgraded Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th. Finally, Redburn Atlantic began coverage on Relx in a report on Wednesday, January 8th. They set a “buy” rating on the stock.
View Our Latest Analysis on Relx
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Articles
- Five stocks we like better than Relx
- How to Find Undervalued Stocks
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- What Are the FAANG Stocks and Are They Good Investments?
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- Health Care Stocks Explained: Why You Might Want to Invest
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.